What Is MET Fair Value?
MetLife (MET) fair value estimate using multiple valuation models, updated daily.
As of October 14, 2026, MetLife (MET) has a composite fair value estimate of $131.67 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $100.65, suggesting the stock is undervalued by 30.8%.
Data as of October 14, 2026 (today)
Composite Fair Value
Undervalued4 of 4 models$131.67
vs. current price of $100.65(+30.8%)
How Is MET Fair Value Calculated?
Four independent models estimate what MET is worth. Each uses different inputs and assumptions. The composite blends them by weight.
MET Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
35% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$146.21
+45.3%Undervalued
Inputs used
DDM (Dividend Discount Model)
15% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
$99.31
-1.3%Fair Value
Inputs used
MET Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
25% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
$99.33
-1.3%Fair Value
Inputs used
PEG (Price/Earnings to Growth)
25% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$126.94
+26.1%Undervalued
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $100.65 is 45.3% below this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $2.68B | $2.51B |
| Year 2 | $3.01B | $2.65B |
| Year 3 | $3.38B | $2.79B |
| Year 4 | $3.81B | $2.94B |
| Year 5 | $4.28B | $3.10B |
| Year 6 | $4.81B | $3.27B |
| Year 7 | $5.41B | $3.45B |
| Year 8 | $6.09B | $3.64B |
| Year 9 | $6.84B | $3.84B |
| Year 10 | $7.70B | $4.05B |
| Terminal Value | $190.40B | $100.07B |
What Are MET's Key Financial Metrics?
Earnings & Growth
Current Price
$100.65
EPS (TTM)
$5.22
Forward P/E
9.0
Profit Margin
4.6%
Cash & Balance Sheet
Free Cash Flow
-21B
EBITDA
6B
Book Value
$43.03
Total Debt
50.3B
What Do Analysts Say About MET?
Low
$84.00
Average
$107.25
High
$119.00
Upside
+6.6%
MET Fair Value FAQ
What is the fair value of MET?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), MET's estimated fair value is $131.67. The stock is currently trading at $100.65, which makes it undervalued by our analysis.
How is MET's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is MET overvalued or undervalued?
Based on our analysis, MET is undervalued. The current price of $100.65 is 30.8% below our estimated fair value of $131.67.
What do Wall Street analysts say about MET?
16 analysts cover MetLife with a consensus rating of "Buy." The average price target is $107.25, ranging from $84.00 to $119.00. This implies 6.6% upside from the current price.